B. Riley et al., NO EVIDENCE FOR LINKAGE OF CHROMOSOME-22 MARKERS TO SCHIZOPHRENIA IN SOUTHERN AFRICAN BANTU-SPEAKING FAMILIES, American journal of medical genetics, 67(6), 1996, pp. 515-522
Previous studies have demonstrated possible linkage between chromosome
22 and one of the hypothesized schizophrenia susceptibility genes. In
terpretation of these data, however, is not straightforward: although
not significant at the level traditionally accepted to demonstrate lin
kage, reported led scores were greater than should have occurred by ch
ance for an unlinked marker based on simulation studies. Further, thes
e studies used sample populations which were either of mixed nationali
ty and ethnicity, or mixed ethnic ancestry from one country. We theref
ore tested for linkage between highly polymorphic chromosome 22 marker
s and schizophrenia in a sample of southern African Bantu-speaking bla
ck families, a population known to have diverged within the last 2,000
years. We also tested one candidate locus, the gene for the soluble f
orm of catechol-O-methyl transferase (COMT) located at 22q11, which ha
s been suggested as the cause of psychiatric symptoms observed in velo
-cardio-facial syndrome (VCFS, including DiGeorge syndrome), and which
is known to be functionally as well as genetically polymorphic. There
is no evidence to support the linkage of markers on chromosome 22 to
susceptibility to schizophrenia in this population, using either param
etric or nonparametric analysis. (C) 1996 Wiley-Liss, Inc.